CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Gabay Avraham Chief Financial Officer | Sale 10b5-1 | −20,000 | $4.51 | $90K | 861,076 |
| 2026-09-24 | Gabay Avraham Chief Financial Officer | Grant or award | +209,291 | 881,076 | ||
| 2026-07-01 | Gabay Avraham Chief Financial Officer | Sale | −73,360 | $4.51 | $331K | 671,785 |
| 2026-03-17 | Gabay Avraham Chief Financial Officer | Grant or award | +95,889 | 745,145 | ||
| 2026-01-22 | Gabay Avraham Chief Financial Officer | Option exercise | +19,000 | 649,256 | ||
| 2026-01-22 | Gabay Avraham Chief Financial Officer | Option exercise · Performance Stock Units | −19,000 | 0 | ||
| 2025-12-31 | Gabay Avraham Chief Financial Officer | Grant or award | +81,216 | 515,256 | ||
| 2025-12-31 | Gabay Avraham Chief Financial Officer | Grant or award | +115,000 | 630,256 | ||
| 2025-12-31 | Gabay Avraham Chief Financial Officer | Grant or award · Performance Stock Units | +19,000 | 19,000 | ||
| 2025-02-11 | Gabay Avraham Chief Financial Officer | Grant or award | +34,000 | 392,040 | ||
| 2025-02-11 | Gabay Avraham Chief Financial Officer | Grant or award | +42,000 | 434,040 | ||
| 2025-01-02 | Gabay Avraham Chief Financial Officer | Grant or award | +188,000 | 358,040 | ||
| 2024-11-07 | Gabay Avraham Chief Financial Officer | Grant or award | +30,000 | 170,040 | ||
| 2024-06-21 | Gabay Avraham Chief Financial Officer | Grant or award | +140,040 | 0 |
Page 1 of 1 · 14 trades